The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,012.00
Bid: 2,000.00
Ask: 2,004.00
Change: 18.00 (0.90%)
Spread: 4.00 (0.20%)
Open: 1,991.00
High: 2,012.00
Low: 1,969.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's opioid deal

Thu, 01st Feb 2024 20:00

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Agrees US-wide settlement designed to resolve its opioid-related claims with US states, local communities and tribal nations. Agrees to pay up to USD115 million in cash and USD35 million in donations of naloxone, an opioid antagonist used to reverse the effects of opioid overdose. Stresses settlement is not an admission of wrongdoing or liability and will continue to defend against any litigation that this settlement does not resolve.

----------

Rockfire Resources PLC - London-based mineral exploration company - Further to announcement of December 12 2023, confirms receipt of USD2 million as part of its terminated acquisition of Emirates Gold DMCC and Emperesse Bullion LLC. These funds will be put towards multiple activities currently being undertaken. Further, says considering avenues and business development strategies to achieve a cash-positive business for investors. Continues to assess opportunities to attract partners to invest in its Queensland projects.

----------

Panther Metals PLC - Canada-focused mineral exploration company - Submits exploration permit application for additional drilling following the discovery of volcanogenic massive sulphide base metal mineralisation on the Wishbone prospect at the Obonga project in northern Ontario. Explains the submitted application covers a planned series of up to 39 diamond core drill holes and associated down-hole geophysics surveys spread across the Wishbone prospect. "With all plans firmly in place we would expect to commence drilling within a relatively short period of time post the granting of the permit," company says.

----------

GCP Asset Backed Income Fund Ltd - London-based investor, which backs medium to long-term fixed or floating rate loans secured against physical assets or cash flows - Receives cash proceeds of GBP18 million from the early partial repayment of a loan secured against a portfolio of property investments. The contractual repayment date of the loan is March 2024. As part of deal, agrees with the relevant borrower in connection with the prepayment, to extend the maturity of the remaining amount of the loan and other loans made to the wider borrower group totalling GBP53.7 million, which are also due in March, to no later than June 29. Also agrees to an increase in the interest rates of the group loan to align with the current credit market conditions. Following the prepayment, estimates cash balance of around GBP50 million. Says has no outstanding balance under its revolving credit facility. Continues to discuss potential GBP7 million share buyback programme with advisers.

----------

Tandem Group PLC - Birmingham, England-based sports and leisure product retailer - Trading update to December 31. Expects annual revenue of GBP22.2 million, down 17% from the prior year, and in line with updated guidance provided in December. Expects annual pretax loss to be in line with guidance. Explains the economic environment in the consumer sector continues to pose challenges and suppressed consumer spending continues to impact the domestic sales market, which proved more challenging than anticipated. Targets 19% increase in 2024 sales to GBP26.5 million and a return to profitability. Annual results will be released on March 25.

----------

First Class Metals PLC - Ontario, Canada-focused exploration company - Announces high-grade gold assays from channel sampling undertaken following the recently completed exploration at the 100% owned Sunbeam property. Describes results as very encouraging and typify this style of mineralisation. Says high grade gold assays reported of up to 18.8 grammes per tonne gold.

----------

Neo Energy Metals PLC - South Africa-focused uranium developer - Reports pretax loss for 18 months to September 30, 2023 of GBP900,000 compared to loss of GBP602,000 for the year ended March 2022. No revenue. Administrative expenses more than doubled to GBP936,000 from GBP457,000 in the shortened trading period. Basic and diluted loss per share was 0.62p compared to LPS of 0.41p.

----------

Emmerson PLC - Morocco-focused potash development company - Announce results of an in-depth scoping study at its Khemisset potash project. Says this substantially improves the Project's economics, with annual earnings before interest, tax, depreciation and amortisation seen at USD440 million per annum compared to original USD258 million. Total project capex now estimated to be USD525 million compared to the original USD539 million. Estimates all-in sustaining cost of USD163 per tonne, at the "lower end of the cost curve" and delivers robust returns across a range of potash price assumptions.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.